Home › Leukemia
Pag-aaral pangklinika para sa Leukemia na nagre-recruit sa U.S.
105 pag-aaral para sa Leukemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX31 pag-aaral
- Boston, MA27 pag-aaral
- New York City, NY21 pag-aaral
- Chicago, IL19 pag-aaral
- Los Angeles, CA17 pag-aaral
- Durham, NC14 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Nashville, TN13 pag-aaral
- Columbus, OH13 pag-aaral
- Philadelphia, PA13 pag-aaral
- Atlanta, GA12 pag-aaral
- Milwaukee, WI12 pag-aaral
- Seattle, WA12 pag-aaral
- Aurora, CO11 pag-aaral
- Birmingham, AL11 pag-aaral
- New Haven, CT10 pag-aaral
- Edison, NJ10 pag-aaral
- Mountain View, CA10 pag-aaral
- Cincinnati, OH10 pag-aaral
- Orange, CA9 pag-aaral
- Dallas, TX9 pag-aaral
- Portland, OR9 pag-aaral
- Queens, NY9 pag-aaral
- Miami, FL9 pag-aaral
- Denver, CO8 pag-aaral
- Buffalo, NY8 pag-aaral
- Clifton, NJ8 pag-aaral
- Washington, DC8 pag-aaral
- Cedar Rapids, IA7 pag-aaral
- Tampa, FL7 pag-aaral
- Charlotte, NC7 pag-aaral
- San Diego, CA6 pag-aaral
- Baltimore, MD6 pag-aaral
- Ann Arbor, MI6 pag-aaral
- Omaha, NE6 pag-aaral
- Detroit, MI5 pag-aaral
- Rochester, MN5 pag-aaral
- Cleveland, OH5 pag-aaral
- Jacksonville, FL5 pag-aaral
- St. Louis, MO5 pag-aaral
Ayos sa estado
- Alabama11 pag-aaral
- Arizona8 pag-aaral
- Arkansas3 pag-aaral
- California30 pag-aaral
- Colorado16 pag-aaral
- Connecticut13 pag-aaral
- Delaware3 pag-aaral
- Florida17 pag-aaral
- Georgia13 pag-aaral
- Illinois20 pag-aaral
- Indiana4 pag-aaral
- Iowa8 pag-aaral
- Kansas6 pag-aaral
- Kentucky6 pag-aaral
- Louisiana4 pag-aaral
- Maine3 pag-aaral
- Maryland12 pag-aaral
- Massachusetts29 pag-aaral
- Michigan9 pag-aaral
- Minnesota9 pag-aaral
- Mississippi3 pag-aaral
- Missouri7 pag-aaral
- Nebraska6 pag-aaral
- New Jersey16 pag-aaral
- New Mexico4 pag-aaral
- New York28 pag-aaral
- North Carolina22 pag-aaral
- North Dakota3 pag-aaral
- Ohio26 pag-aaral
- Oklahoma5 pag-aaral
- Oregon10 pag-aaral
- Pennsylvania16 pag-aaral
- Rhode Island5 pag-aaral
- South Carolina7 pag-aaral
- Tennessee15 pag-aaral
- Texas33 pag-aaral
- Utah5 pag-aaral
- Vermont5 pag-aaral
- Virginia8 pag-aaral
- Washington12 pag-aaral
- West Virginia3 pag-aaral
- Wisconsin14 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
CD70.CAR for AML and Other CD70+ Leukemias
Nagre-recruitPhase 1
Hanggang edad 75 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06345027Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00923507Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07007312Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Nagre-recruitPhase 2
Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07354074Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06856226Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 5 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT05237986A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07751991cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06229912Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Nagre-recruitPhase 3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07504458A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06520098Mosaic Trial for Stem Cell Transplant Recipients
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06960993A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07614022Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06265584Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801Natural History Study of GATA2 Deficiency and Related Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT01905826HEME Home Transfusion Program
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06487247Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01137643Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07356245Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT00736749A Study of Revumenib and Mezigdomide in People With Leukemia
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07356154Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT05745285AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT06137118A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
30 Days · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT04065399Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.